Intravenous Anaesthetic Agents

(excluding ketamine)

  • Propofol, thiopentone and etomidate all reduce CMR
  • As a result of flow–metabolism coupling they all result in a fall in cerebral blood flow
  • Autoregulation is not affected
Ketamine
  • Causes increased cerebral blood flow
    • Increases cardiac output and MAP
    • Increases CMR and dilates cerebral vasculature
  • Counteracts mild increase in ICP to maintain perfusion
Volatile Anaesthetic Agents

(excluding N2O)

  • Unique in their ability to uncouple CMR and CBF:
    • Cause a decrease in CMR
    • However, also abolish autoregulation and cause cerebral arteriolar vasodilatation, leading to increased CBF
  • The action is dose-dependent:
    • Below 1 MAC both effects are approximately equal and CBF is unchanged
    • Above 1 MAC the reduction in CMR is already maximal and CBF increases due to cerebral arteriolar vasodilatation
  • Sevoflurane has the lowest vasodilatory potential of the volatile agents
    • Order of vasodilating potency is halothane > enflurane > desflurane > isoflurane > sevoflurane
N2O
  • Both potently dilates cerebral arteries and increases CMR
  • As a result CBF significantly increases
Opioids
  • No significant effect on either CMR or CBF
  • CBF will rise in the setting of opioid induced CO2 retention
NMBA
  • No significant effect on either CMR or CBF